Teva Pharmaceutical Industries Ltd. and its Cephalon unit lost their European Union court case over a €60.5 million ($64 million) antitrust fine for a pact that delayed sales of a cheaper version of a sleep-disorder drug.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,